Galmed Pharma (GLMD) Reports In-Line Q4 EPS
Galmed Pharma (NASDAQ: GLMD) reported Q4 EPS of ($0.30), in-line with the analyst estimate of ($0.30).
For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.
Galmed Pharma (NASDAQ: GLMD) reported Q4 EPS of ($0.30), in-line with the analyst estimate of ($0.30).
For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.